Figure 1. Expression of GPI-80 on purified CB-derived 18LinCD34+CD38 and 18LinCD34 cells and frequencies of SRCs in these purified cells
Figure 1. Expression of GPI-80 on purified CB-derived 18Lin−CD34+CD38− and 18Lin−CD34− cells and frequencies of SRCs in these purified cells. (A) The representative FACS profiles of CB-derived 18Lin−CD34+CD38−GPI-80+/− and 18Lin−CD34−GPI-80+/− cells (i to vi) and (B) a comparison of the frequency of SRCs in CB-derived 18Lin−CD34+CD38−GPI-80+/− and 18Lin−CD34−GPI-80+/− cells (i to iv). (A) (i) The forward scatter/side scatter (FSC/SSC) profile of immunomagnetically separated Lin− cells. The R1 gate was set on the blast-lymphocyte window. (ii) The R2 gate was set on the 18Lin− living cells. (iii) The 18Lin− living cells (R2) were subdivided into 2 fractions: 18Lin−CD45+CD34+ (R3) and 18Lin−CD45+CD34− (R4) cells, according to their CD34 expression levels. CD34+/− cells were defined as follows: the CD34+ fraction contains cells expressing maximum antigen-presenting cell fluorescence intensity (FI) to the 5% level of FI. The CD34− level of FI was determined based on Fluorescence Minus One controls. (iv) The 18Lin−CD45+CD34+ cells residing in the R3 gate were further subdivided into CD38− (R5) cells, according to their CD38 expression levels. The CD38− level was defined as <15% of the maximum PE-Cy7 FI. (v) The 18Lin−CD45+CD34+CD38− cells residing in the R5 gate were further subdivided into 2 fractions: 18Lin−CD45+CD34+CD38−GPI-80+ (R6) and GPI-80− (R7) cells, according to their GPI-80 expression levels. GPI-80+/− cells were defined as follows: the GPI-80− level of FI was determined based on Fluorescence Minus One controls, and remaining cells were defined as GPI-80+ cells. (vi) The R4-gated cells were further subdivided into 2 fractions: 18Lin−CD45+CD34−GPI-80+ (R8) and GPI-80− (R9) cells. The definitions of GPI-80+/− cells are the same as abovementioned. As shown in (v) and (vi), the percentages of GPI-80+ cells in the CD34+ (R6) and CD34− (R8) fractions ranged from 5.4% to 19.9% (mean 11.8%, n = 6) and 5.4% to 29.9% (mean 14.2%, n = 6), respectively. (B) Various numbers of 18Lin−CD34+CD38−GPI-80+ cells (1, 2, and 8, n = 32) (i), 18Lin−CD34+CD38−GPI-80− cells (40, 80, and 160, n = 11) (ii), 18Lin−CD34−GPI-80+ cells (10, 20, 50, 100, 200, and 400, n = 26) (iii), and 18Lin−CD34−GPI-80− cells (500, 1000, and 2000, n = 15) (iv) were transplanted into NOG mice. The human CD45+ cell repopulation in the mouse BM was analyzed by FCM at 8 weeks after transplantation. The frequency of SRC was 1 per 20.7 in 18Lin−CD34+CD38−GPI-80+ cells, 1 per 35.4 in 18Lin−CD34+CD38−GPI-80− cells, 1 per 27.5 in 18Lin−CD34−GPI-80+ cells, and 1 per 874 in 18Lin−CD34−GPI-80− cells. The middle solid line represents the estimated weighted mean frequency (fWM). The lower and upper dotted lines represent the 95% confidence interval of fWM. The detailed LDA data are presented in supplemental Table 2.

(A) The representative FACS profiles of CB-derived 18LinCD34+CD38GPI-80+/− and 18LinCD34GPI-80+/− cells (i to vi) and (B) a comparison of the frequency of SRCs in CB-derived 18LinCD34+CD38GPI-80+/− and 18LinCD34GPI-80+/− cells (i to iv). (A) (i) The forward scatter/side scatter (FSC/SSC) profile of immunomagnetically separated Lin cells. The R1 gate was set on the blast-lymphocyte window. (ii) The R2 gate was set on the 18Lin living cells. (iii) The 18Lin living cells (R2) were subdivided into 2 fractions: 18LinCD45+CD34+ (R3) and 18LinCD45+CD34 (R4) cells, according to their CD34 expression levels. CD34+/− cells were defined as follows: the CD34+ fraction contains cells expressing maximum antigen-presenting cell fluorescence intensity (FI) to the 5% level of FI. The CD34 level of FI was determined based on Fluorescence Minus One controls. (iv) The 18LinCD45+CD34+ cells residing in the R3 gate were further subdivided into CD38 (R5) cells, according to their CD38 expression levels. The CD38 level was defined as <15% of the maximum PE-Cy7 FI. (v) The 18LinCD45+CD34+CD38 cells residing in the R5 gate were further subdivided into 2 fractions: 18LinCD45+CD34+CD38GPI-80+ (R6) and GPI-80 (R7) cells, according to their GPI-80 expression levels. GPI-80+/− cells were defined as follows: the GPI-80 level of FI was determined based on Fluorescence Minus One controls, and remaining cells were defined as GPI-80+ cells. (vi) The R4-gated cells were further subdivided into 2 fractions: 18LinCD45+CD34GPI-80+ (R8) and GPI-80 (R9) cells. The definitions of GPI-80+/− cells are the same as abovementioned. As shown in (v) and (vi), the percentages of GPI-80+ cells in the CD34+ (R6) and CD34 (R8) fractions ranged from 5.4% to 19.9% (mean 11.8%, n = 6) and 5.4% to 29.9% (mean 14.2%, n = 6), respectively. (B) Various numbers of 18LinCD34+CD38GPI-80+ cells (1, 2, and 8, n = 32) (i), 18LinCD34+CD38GPI-80 cells (40, 80, and 160, n = 11) (ii), 18LinCD34GPI-80+ cells (10, 20, 50, 100, 200, and 400, n = 26) (iii), and 18LinCD34GPI-80 cells (500, 1000, and 2000, n = 15) (iv) were transplanted into NOG mice. The human CD45+ cell repopulation in the mouse BM was analyzed by FCM at 8 weeks after transplantation. The frequency of SRC was 1 per 20.7 in 18LinCD34+CD38GPI-80+ cells, 1 per 35.4 in 18LinCD34+CD38GPI-80 cells, 1 per 27.5 in 18LinCD34GPI-80+ cells, and 1 per 874 in 18LinCD34GPI-80 cells. The middle solid line represents the estimated weighted mean frequency (fWM). The lower and upper dotted lines represent the 95% confidence interval of fWM. The detailed LDA data are presented in supplemental Table 2.

Close Modal

or Create an Account

Close Modal
Close Modal